Suchergebnisse - "Bahlis, Nizar"

PubPharm (269)

1

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in MajesTEC-1

enthalten in: Blood | 2024

von Cortes-Selva, D. | Perova, T. | Skerget, S. | +22

2

Plain Language Summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma

enthalten in: Future oncology (London, England) | 2024

von Rodriguez-Otero, P. | Ailawadhi, S. | Arnulf, B. | +19

3

Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma

enthalten in: Cancer | 2024

von Suvannasankha, A. | Bahlis, N. | Trudel, S. | +17

4

Artificial Intelligence Individualized Risk Classifier in Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Neri, P. | Lee, H. | Bahlis, N.

5

BCMA- or GPRC5D-targeting bispecific antibodies in multiple myeloma : efficacy, safety, and resistance mechanisms

enthalten in: Blood | 2024

von Lee, H. | Neri, P. | Bahlis, N.

6

Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma

enthalten in: Advances in therapy | 2024

von Einsele, H. | Moreau, P. | Bahlis, N. | +23

7

Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma : Results From the Phase II MajesTEC-1 Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Martin, T. | Moreau, P. | Usmani, S. | +20

8

Correction : GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review

enthalten in: Blood cancer journal | 2024

von Rodriguez-Otero, P. | van de Donk, N. | Pillarisetti, K. | +13

ErratumFor: Blood Cancer J. 2024 Feb 2;14(1):24. - PMID 38307865

9

Cereblon-Targeting Ligase Degraders in Myeloma : Mechanisms of Action and Resistance

enthalten in: Hematology/oncology clinics of North America | 2024

von Lee, H. | Neri, P. | Bahlis, N.

10

Smoldering Multiple Myeloma : Taking the narrow over the wide path?

enthalten in: Blood | 2024

von Avet-Loiseau, H. | Bahlis, N.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]